Inflammatory bowel disease (IBD) consists of two distinct clinical forms, ulcerative colitis (UC) and Crohn s disease (CD), with unknown aetiology, which nevertheless are considered to share almost identical pathophysiological backgrounds. Up to date, a full coherent mechanistic explanation for IBD is still lacking, but people start to realize that the pathogenesis of IBD involves four fundamental components: the environment, gut microbiota, the immune system and the genome. As a consequence, IBD development might be due to an altered immune response and a disrupted mechanism of host tolerance to the non-pathogenic resident microbiota, leading to an elevated inflammatory response. Considering the available data arising from the scientific literature, here reviewed, in CD, a benefit of probiotics remains unproven; in UC, a benefit of probiotics remains unproven, even if E. coli Nissle 1917seems promising in maintaining remission and it could be considered an alternative in patients intolerant or resistant to 5-ASA preparations; in pouchitis, small controlled trials suggest a benefit from VSL no. 3 in the primary and secondary prevention of pouchitis; in IBD-associated conditions, a benefit of probiotics remains unproven. However, well-designed randomized control clinical trials are necessary to understand the undoubted role of these agents in the management of gut physiology in health and disease.

Sinagra, E., Tomasello, G., Cappello, F., Leone, A., Cottone, M., Bellavia, M., et al. (2013). Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 27(4), 919-933.

Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights

TOMASELLO, Giovanni;CAPPELLO, Francesco;LEONE, Angelo;COTTONE, Mario;DAMIANI, Francesco;ABBRUZZO, Antonino;Damiano, G;PALUMBO, Vincenzo Davide;SPINELLI, Gabriele;LO MONTE, Attilio Ignazio;SINAGRA, Emanuele
2013-01-01

Abstract

Inflammatory bowel disease (IBD) consists of two distinct clinical forms, ulcerative colitis (UC) and Crohn s disease (CD), with unknown aetiology, which nevertheless are considered to share almost identical pathophysiological backgrounds. Up to date, a full coherent mechanistic explanation for IBD is still lacking, but people start to realize that the pathogenesis of IBD involves four fundamental components: the environment, gut microbiota, the immune system and the genome. As a consequence, IBD development might be due to an altered immune response and a disrupted mechanism of host tolerance to the non-pathogenic resident microbiota, leading to an elevated inflammatory response. Considering the available data arising from the scientific literature, here reviewed, in CD, a benefit of probiotics remains unproven; in UC, a benefit of probiotics remains unproven, even if E. coli Nissle 1917seems promising in maintaining remission and it could be considered an alternative in patients intolerant or resistant to 5-ASA preparations; in pouchitis, small controlled trials suggest a benefit from VSL no. 3 in the primary and secondary prevention of pouchitis; in IBD-associated conditions, a benefit of probiotics remains unproven. However, well-designed randomized control clinical trials are necessary to understand the undoubted role of these agents in the management of gut physiology in health and disease.
2013
Settore BIO/17 - Istologia
Sinagra, E., Tomasello, G., Cappello, F., Leone, A., Cottone, M., Bellavia, M., et al. (2013). Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS, 27(4), 919-933.
File in questo prodotto:
File Dimensione Formato  
Sinagra paper.pdf

accesso aperto

Descrizione: PDF
Dimensione 1.29 MB
Formato Adobe PDF
1.29 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/88444
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 26
social impact